{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:22:13Z","timestamp":1786119733993,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1097\/coc.0b013e318209a8f8","type":"journal-article","created":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T04:19:25Z","timestamp":1298002765000},"page":"105-109","source":"Crossref","is-referenced-by-count":11,"title":["Efficacy and Tolerability of long-acting Octreotide in the Treatment of Thymic Tumors"],"prefix":"10.1097","volume":"35","author":[{"given":"Flavia","family":"Longo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucilla","family":"De Filippis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Zivi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Vitolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Del Signore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Gori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Diso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Anile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Venuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziano","family":"De Giacomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camillo Furio","family":"Coloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210128","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-1-4615-1589-0_11","article-title":"Thymic malignancies.","volume":"105","author":"Loehrer","year":"2001","journal-title":"Cancer Treat Res"},{"key":"R2-2-20210128","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/cncr.10665","article-title":"New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China.","volume":"95","author":"Chen","year":"2002","journal-title":"Cancer"},{"key":"R3-2-20210128","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.hoc.2008.03.001","article-title":"Histologic classification of thymoma: the World Health Organization and beyond.","volume":"22","author":"Suster","year":"2008","journal-title":"Hematol Oncol Clin North Am"},{"key":"R4-2-20210128","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0003-4975(00)01140-1","article-title":"Prognostic relevance of Masaoka and Muller-Hermelink classification in patients with thymic tumors.","volume":"69","author":"Lardinois","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"R5-2-20210128","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","article-title":"Follow-up study of thymomas with special reference to their clinical stages.","volume":"48","author":"Masaoka","year":"1981","journal-title":"Cancer"},{"key":"R6-2-20210128","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/00000478-199612000-00006","article-title":"Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma. A clinicopathologic study of 22 cases.","volume":"20","author":"Suster","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"R7-2-20210128","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/jso.1146","article-title":"Recurrence of thymoma: clinicopathological features, re-operation, and outcome.","volume":"78","author":"Haniuda","year":"2001","journal-title":"J Surg Oncol"},{"key":"R8-2-20210128","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF03032284","article-title":"Oncological significance of WHO histological thymoma classification. A clinical study based on 286 patients.","volume":"50","author":"Okumura","year":"2002","journal-title":"Jpn J Thorac Cardiovasc Surg"},{"key":"R10-2-20210128","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0003-4975(03)00555-1","article-title":"Therapy for thymic epithelial tumors: a clinical study of 1320 patients from Japan.","volume":"76","author":"Kondo","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"R11-2-20210128","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1053\/stcs.2000.17955","article-title":"Current status of the diagnosis and treatment of thymoma.","volume":"12","author":"Graeber","year":"2000","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"R12-2-20210128","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/00004728-200105000-00010","article-title":"Invasive and noninvasive thymoma: distinctive CT features.","volume":"25","author":"Tomiyama","year":"2001","journal-title":"J Comput Assist Tomogr"},{"key":"R13-2-20210128","first-page":"1187","article-title":"Diagnosis, treatment and prognosis of thymoma: an analysis of 116 cases.","volume":"116","author":"Wang","year":"2003","journal-title":"Chin Med J (Engl)"},{"key":"R14-2-20210128","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.lungcan.2003.12.010","article-title":"Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report.","volume":"44","author":"Kim","year":"2004","journal-title":"Lung Cancer"},{"key":"R15-2-20210128","first-page":"634","article-title":"In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy.","volume":"39","author":"Lastoria","year":"1998","journal-title":"J Nucl Med"},{"key":"R16-2-20210128","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0344-0338(99)80008-9","article-title":"Somatostatin receptor scintigraphy in thymoma imaging method and clinical application.","volume":"195","author":"Marienhagen","year":"1999","journal-title":"Pathol Res Pract"},{"key":"R17-2-20210128","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/qjmed\/91.4.295","article-title":"Localization of neuroendocrine tumours with 111In DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging.","volume":"91","author":"Shi","year":"1998","journal-title":"QJM"},{"key":"R18-2-20210128","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1056\/NEJM199701233360405","article-title":"Successful treatment of a patient with a thymoma and pure red cell aplasia with octreotide plus prednisone.","volume":"336","author":"Palmieri","year":"1997","journal-title":"N Engl J Med"},{"key":"R19-2-20210128","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1200\/JCO.2004.02.047","article-title":"Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial.","volume":"22","author":"Loehrer","year":"2004","journal-title":"J Clin Oncol"},{"key":"R20-2-20210128","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1).","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"R22-2-20210128","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/0024-3205(95)02082-T","article-title":"The somatostatin receptor family.","volume":"57","author":"Patel","year":"1995","journal-title":"Life Sci"},{"key":"R23-2-20210128","first-page":"2","article-title":"Somatostatin receptor expression: therapeutic considerations.","volume":"20","author":"Bruns","year":"1997","journal-title":"J Endocrinol Invest"},{"key":"R24-2-20210128","first-page":"427","article-title":"Molecular biology of somatostatin receptors.","volume":"16","author":"Reisine","year":"1995","journal-title":"Endocr Rev"},{"key":"R25-2-20210128","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1210\/jcem.85.4.6547","article-title":"Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro.","volume":"85","author":"Ferone","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-2-20210128","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1210\/endo.140.1.6398","article-title":"In vitro characterization of somatostatin receptors in the human thymus and effects of somatostatin and octreotide on cultured thymic epithelial cells.","volume":"140","author":"Ferone","year":"1999","journal-title":"Endocrinology"},{"key":"R27-2-20210128","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1172\/JCI118618","article-title":"Induction of a negative autocrine loop by expression of SST2 somatostatin receptor in NIH 3T3 cells.","volume":"97","author":"Rauly","year":"1996","journal-title":"J Clin Invest"},{"key":"R28-2-20210128","first-page":"187","article-title":"A tyrosine phosphatase is associated with the somatostatin receptor.","volume":"190","author":"Delesque","year":"1995","journal-title":"Ciba Found Symp"},{"key":"R29-2-20210128","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1073\/pnas.92.5.1580","article-title":"Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through difference mechanisms.","volume":"92","author":"Buscail","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R30-2-20210128","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0026-0495(96)90077-3","article-title":"Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels.","volume":"45","author":"Reubi","year":"1996","journal-title":"Metabolism"},{"key":"R31-2-20210128","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0163-7258(93)90009-3","article-title":"Somatostatin analogs for diagnosis and treatment of cancer.","volume":"60","author":"Weckbecker","year":"1993","journal-title":"Pharmacol Ther"},{"key":"R32-2-20210128","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s002590050034","article-title":"Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use.","volume":"27","author":"Reubi","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"R33-2-20210128","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00003072-199901000-00006","article-title":"Somatostatin receptor scintigraphy and somatostatin therapy in the evaluation and treatment of malignant thymoma.","volume":"24","author":"Lin","year":"1999","journal-title":"Clin Nucl Med"},{"key":"R34-2-20210128","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/cncr.10374","article-title":"Somatostatin analogs and prednisone in advanced refractory thymic tumors.","volume":"94","author":"Palmieri","year":"2002","journal-title":"Cancer"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/COC.0b013e318209a8f8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:52:51Z","timestamp":1786042371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000421-201204000-00002"}},"subtitle":["Results of a Pilot Trial"],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0b013e318209a8f8","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}